SynHelix Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • M&A

SynHelix General Information

Description

Operator of a biotechnology company intended to develop an affordable DNA synthesis technology. The company is engaged in generating any DNA construct without constraints of sequence, length, or quantity, with properly achievable purity, enabling life sciences laboratories and industries to avail themselves with an enzyme-based DNA synthesis service that promises a gigaprep-scale DNA production.

Contact Information

Formerly Known As
Ina Biotherapeutics
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 6-18 Rue du Pelvoux
  • 91080 Évry-Courcouronnes
  • France
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 6-18 Rue du Pelvoux
  • 91080 Évry-Courcouronnes
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SynHelix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 06-Jan-2022 Completed Generating Revenue
1. Early Stage VC 19-Jun-2020 Completed Generating Revenue
To view SynHelix’s complete valuation and funding history, request access »

SynHelix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
ABSA
ADP 2019
To view SynHelix’s complete cap table history, request access »

SynHelix Patents

SynHelix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023031333-A1 Polymeric soluble support, process for the synthesis thereof and uses thereof Inactive 01-Sep-2021
US-20240123419-A1 Tubular reaction unit Pending 14-Apr-2021
WO-2022219164-A1 Tubular reaction unit Inactive 14-Apr-2021
US-20240100533-A1 Device for thermocycled multistep reactions Pending 05-Feb-2021
WO-2022167616-A1 Device for thermocycled multistep reactions Inactive 05-Feb-2021 B01L7/52
To view SynHelix’s complete patent history, request access »

SynHelix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SynHelix Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
AdBio partners Venture Capital Minority
To view SynHelix’s complete investors history, request access »

SynHelix FAQs

  • When was SynHelix founded?

    SynHelix was founded in 2019.

  • Where is SynHelix headquartered?

    SynHelix is headquartered in Évry-Courcouronnes, France.

  • What is the size of SynHelix?

    SynHelix has 20 total employees.

  • What industry is SynHelix in?

    SynHelix’s primary industry is Discovery Tools (Healthcare).

  • Is SynHelix a private or public company?

    SynHelix is a Private company.

  • What is SynHelix’s current revenue?

    The current revenue for SynHelix is .

  • How much funding has SynHelix raised over time?

    SynHelix has raised $837K.

  • Who are SynHelix’s investors?

    AdBio partners has invested in SynHelix.

  • When was SynHelix acquired?

    SynHelix was acquired on 06-Jan-2022.

  • Who acquired SynHelix?

    SynHelix was acquired by Univercells.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process